Merrimack Pharmaceuticals

Filed a patent for "liposomes useful for drug delivery" on Thu, June 15, 2023

Filed a patent for "bi-specific fusion proteins" on Thu, October 12, 2023

Filed a patent for "inhibiting ataxia telangiectasia and rad3-related protein (atr)" on Thu, December 28, 2023

Filed a patent for "bi-specific fusion proteins" on Thu, March 28, 2024

Filed a patent for "nanoliposomal irinotecan for use in treating small cell lung cancer" on Thu, January 5, 2023

Filed a patent for "combination therapy for cancer treatment" on Thu, March 9, 2023

Filed a patent for "methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin" on Thu, March 2, 2023

Filed a patent for "stabilizing camptothecin pharmaceutical compositions" on Thu, April 6, 2023